<DOC>
	<DOCNO>NCT00185081</DOCNO>
	<brief_summary>The purpose study test safety peptide antibody time evaluate tumor image two step antibody technique nuclear imaging .</brief_summary>
	<brief_title>Imaging Colo-rectal Cancer Using Two Step Antibody Technique Nuclear Imaging</brief_title>
	<detailed_description>Colo-rectal cancer incidence 8000 case per year The Netherlands . Eventually 50 % die consequence disease . Treatment consist resection primary tumor , follow adjuvant chemotherapy patient . The chemotherapeutical agent , however , moderately effective regard increase survival . New treatment modality therefore desirable . Radioimmunotherapy use radioactive labelled antibody proven effective hematologic malignancy . Due slow absorption solid tumor however effective radiation dose yet achieve . The aim study bypass slow tumor uptake use pre-targeting . We therefore use unlabeled bispecific antibody infusion . This follow several day later infusion radiolabeled peptide bind bispecific antibody . We hypothesise small peptide readily absorb tumor pre-saturated bispecific antibody . As consequence high radiation dose give low toxicity .</detailed_description>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>&gt; 18 year age Histologic cytologic diagnosis colorectal cancer Karnofsky performance status &gt; 70 % Pregnant lactate woman Severe anorexia Active second primary malignancy Chemotherapy radiotherapy within four week study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>colon cancer</keyword>
	<keyword>radioimmunoscintigraphy</keyword>
	<keyword>colon-specific antigen ,</keyword>
	<keyword>radioimmunotherapy ,</keyword>
	<keyword>radioimmunodetection</keyword>
</DOC>